Latest News and Press Releases

VANCOUVER, British Columbia, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and twelve months ended June 30, 2018....

VANCOUVER, British Columbia, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, announced today that it has...

VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSX-V:NVH) (FWB:3NH) is pleased to announce a presentation was delivered on June 22nd, 2018,...

VANCOUVER, British Columbia, June 13, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that its...

HONG KONG, June 06, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, is pleased to announce that its wholly owned...

Participation positions the Company to help define future industry and regulatory standards for effective cardiotoxicity screening of all newly developed drugs VANCOUVER, British Columbia, May 31,...

VANCOUVER, British Columbia, May 11, 2018 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and nine months ended March 31, 2018....

ISSCR Meeting in Melbourne to host over 4,000 attendees including notable scientists, innovators, industry representatives and mediaNovoheart’s proprietary ‘Human heart-in-a-jar 2.0’ now enhanced with...

VANCOUVER, British Columbia, April 12, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH) is pleased to announce that Dr. Ronald Li, Founder and CEO of the...

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2018) - Novoheart ("Novoheart" or the "Company") (TSX VENTURE:NVH) is pleased to announce the successful completion of a second...